Pharvaris N.V.
PHVS
$28.41
$4.2917.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.42M | -51.62M | -48.77M | -37.05M | -45.86M |
| Total Depreciation and Amortization | 122.90K | 116.90K | 110.80K | 97.00K | 47.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.28M | 13.85M | 10.58M | -4.48M | 10.76M |
| Change in Net Operating Assets | 2.16M | 3.63M | -2.41M | 4.18M | -1.52M |
| Cash from Operations | -35.86M | -34.03M | -40.49M | -37.26M | -36.57M |
| Capital Expenditure | -21.90K | 18.90K | -169.40K | -171.50K | -336.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -21.90K | 18.90K | -169.40K | -171.50K | -336.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.90K | -23.30K | -104.50K | -26.60K | -25.80K |
| Issuance of Common Stock | 171.37M | 400.00 | 29.10K | 592.70K | 1.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.91M | -- | -- | 0.00 | -1.00K |
| Cash from Financing | 187.57M | -26.00K | -79.40K | 603.50K | 1.09M |
| Foreign Exchange rate Adjustments | -38.00K | -7.87M | -5.81M | 10.75M | -6.38M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.65M | -41.91M | -46.55M | -26.08M | -42.20M |